Skip to main content

Microbiome

0
Pipeline Programs
5
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
16s rRNA or shotgun metagenomicsN/A1 trial
Active Trials
NCT06659237Completed121Est. May 2024
Biomed
BiomedAustralia - Sydney
1 program
MaltodextrinN/A1 trial
Active Trials
NCT04114513Withdrawn0Est. Sep 2020
Allergy Therapeutics
Allergy TherapeuticsUK - West Sussex
1 program
Study of Antibiotic-induced Vaginal Yeast Infections in Healthy WomenN/A1 trial
Active Trials
NCT01915251Terminated13Est. Sep 2019
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
strawberry powderN/A1 trial
Active Trials
NCT04217122Completed30Est. Dec 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
UNION therapeutics16s rRNA or shotgun metagenomics
BiomedMaltodextrin
Angeles Therapeuticsstrawberry powder
Allergy TherapeuticsStudy of Antibiotic-induced Vaginal Yeast Infections in Healthy Women

Clinical Trials (4)

Total enrollment: 164 patients across 4 trials

NCT06659237UNION therapeutics16s rRNA or shotgun metagenomics

Fecal and Oral Microbiota Between Pancreatic Cancer and Benign/Low-grade Malignant Tumor Patients

Start: Nov 2020Est. completion: May 2024121 patients
N/ACompleted
NCT04114513BiomedMaltodextrin

Dietary Fibers Effect on the Gut Microbiota Composition

Start: Nov 2019Est. completion: Sep 20200
N/AWithdrawn
NCT04217122Angeles Therapeuticsstrawberry powder

Effect of Strawberry Consumption on the Microbiome

Start: Sep 2018Est. completion: Dec 201930 patients
N/ACompleted
NCT01915251Allergy TherapeuticsStudy of Antibiotic-induced Vaginal Yeast Infections in Healthy Women

Study of Antibiotic-induced Vaginal Yeast Infections in Healthy Women

Start: Jul 2013Est. completion: Sep 201913 patients
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.